Sign up to save your podcasts
Or
Share Businessweek Talks- Compass Pathways CEO George Goldsmith
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Businessweek Talks- Compass Pathways CEO George Goldsmith
George Goldsmith, CEO at Compass Pathways, discusses show he developed a synthetic form of psilocybin, the psychoactive ingredient found in “magic mushrooms,” for use in treating depression. Goldsmith speaks with Bloomberg Businessweek anchor Carol Massar for the latest edition of Businessweek Talks.
Producer: Doni Holloway.
See omnystudio.com/listener for privacy information.
View all episodes
By Bloomberg
3.7
376376 ratings
George Goldsmith, CEO at Compass Pathways, discusses show he developed a synthetic form of psilocybin, the psychoactive ingredient found in “magic mushrooms,” for use in treating depression. Goldsmith speaks with Bloomberg Businessweek anchor Carol Massar for the latest edition of Businessweek Talks.
Producer: Doni Holloway.
See omnystudio.com/listener for privacy information.
More shows like Bloomberg Businessweek
View all
WSJ Your Money Briefing
1,731 Listeners
Exchanges
981 Listeners
Bloomberg Intelligence
409 Listeners
Bloomberg Surveillance
1,182 Listeners
Masters in Business
2,192 Listeners
Foundering
969 Listeners
WSJ Minute Briefing
685 Listeners
Trillions
193 Listeners
Wall Street Breakfast
1,043 Listeners
Thoughts on the Market
1,313 Listeners
Here's Why
65 Listeners
Out of Office
30 Listeners
Wall Street Week
62 Listeners
Listen to the Story
4 Listeners
Into the Metaverse
58 Listeners
Bedrock, USA
233 Listeners
Zero: The Climate Race
228 Listeners
Bloomberg Tech
63 Listeners
Bloomberg Daybreak: US Edition
86 Listeners
The Markets
81 Listeners
Bloomberg News Now
83 Listeners
The Deal with Alex Rodriguez and Jason Kelly
81 Listeners
Money Stuff: The Podcast
408 Listeners
Bloomberg Daybreak: Asia Edition
10 Listeners
Bloomberg Talks
22 Listeners
In the City
12 Listeners
Bloomberg Opinion
7 Listeners
The Cable
2 Listeners
IVF Disrupted: The Kindbody Story
114 Listeners
Stock Movers
24 Listeners